142 related articles for article (PubMed ID: 38389401)
1. Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study.
Ebad Ur Rehman M; Faraz F; Cheema HA; Ashruf OS; Raheel H; Naqvi SZA; Jabeen N; Abid A; Mumtaz Malik H; Iftikhar A; Ibrahim A; Swed S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1984. PubMed ID: 38389401
[TBL] [Abstract][Full Text] [Related]
2. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract][Full Text] [Related]
3. Impact of prior cancer history on the survival of patients with larynx cancer.
Zhu K; Lin R; Zhang Z; Chen H; Rao X
BMC Cancer; 2020 Nov; 20(1):1137. PubMed ID: 33228622
[TBL] [Abstract][Full Text] [Related]
4. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
5. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Gallbladder Cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract][Full Text] [Related]
6. Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score-Adjusted, Population-Based Study.
Lin C; Wu J; Ding S; Goh C; Andriani L; Shen K; Zhu L
Cancer Res Treat; 2020 Apr; 52(2):552-562. PubMed ID: 31801318
[TBL] [Abstract][Full Text] [Related]
7. Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
Zhu P; Du XL; Hwang LY; Lairson D; Li R; Esquenazi Y; Zhu JJ
Sci Rep; 2023 Feb; 13(1):3266. PubMed ID: 36841851
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes in esophageal cancer patients with a prior cancer.
Pan D; Xu W; Gao X; Yiyang F; Wei S; Zhu G
Medicine (Baltimore); 2021 Feb; 100(7):e24798. PubMed ID: 33607840
[TBL] [Abstract][Full Text] [Related]
9. Effect of prior cancer on survival outcomes for patients with advanced prostate cancer.
Wu Y; Chen X; Qian D; Wang W; Zhang Y; Hu J; Zhu J; Wu Q; Cao T
BMC Urol; 2021 Feb; 21(1):26. PubMed ID: 33596896
[TBL] [Abstract][Full Text] [Related]
10. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
11. Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed HH; Ibrahim Sokkar M; Afifi AM; Saad AM; Albarouki S; Al-Husseini MJ
J Obstet Gynaecol; 2020 Feb; 40(2):233-239. PubMed ID: 31352852
[TBL] [Abstract][Full Text] [Related]
12. Impact of prior cancer history on survival of patients with hypopharyngeal cancer.
Liang QW; Hong SY; Peng L; Liao J; Wen WP; Sun W
Cancer Med; 2023 Feb; 12(3):2929-2936. PubMed ID: 36057955
[TBL] [Abstract][Full Text] [Related]
13. The impact of a prior malignancy on outcomes in gastric cancer patients.
Bian X; Wang K; Wang Q; Yang L; Xia J; Wu W; Li L
Cancer Med; 2021 Feb; 10(4):1457-1470. PubMed ID: 33470048
[TBL] [Abstract][Full Text] [Related]
14. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
15. Impact of prior cancer history on outcomes in thymoma: a propensity score, population-based study.
Wu S; Peng G; Liang W; He J
Gland Surg; 2021 May; 10(5):1618-1626. PubMed ID: 34164306
[TBL] [Abstract][Full Text] [Related]
16. Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.
Wang X; Wang Z; Chen Y; Lin Q; Chen H; Lin Y; Lu L; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103235. PubMed ID: 34563802
[TBL] [Abstract][Full Text] [Related]
17. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
18. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
[TBL] [Abstract][Full Text] [Related]
19. Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.
Zhou H; Huang Y; Qiu Z; Zhao H; Fang W; Yang Y; Zhao Y; Hou X; Ma Y; Hong S; Zhou T; Zhang Y; Zhang L
Int J Cancer; 2018 Oct; 143(7):1569-1577. PubMed ID: 29667174
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Prior Nonpancreatic Malignancy on Survival Outcomes of Patients With Stage IV Pancreatic Neuroendocrine Tumor: A Population-Based and Propensity Score Matching Study.
Li G; Tian ML; Bing YT; Yuan CH; Xiu DR
Pancreas; 2020 Sep; 49(8):1090-1098. PubMed ID: 32833943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
